Cetera Advisors’s Pfizer PFE Stock Holding History

Cetera Advisors’s Portfolio PFE Stock Details PFE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q3	–	Sell	-422	Closed	-$1K	–	858
2017 Q2	$1K	Buy	+422	New	+$13.3K	﹤0.01%	823

Other funds holding PFE

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

Cetera Advisors's PFE Position: Q1 2024 in Review

Cetera Advisors increased its Pfizer (PFE) stake by 99% in Q1 2024, buying an estimated $12.9M and bringing the position to 935,637 shares worth $26M. The position accounts for 0.2% of the portfolio, ranked #102.

Cetera Advisors first reported a position in PFE in Q2 2013 and has held it in 44 quarters since. 2,874 funds tracked by Wall St. Rank hold PFE as of Q1 2024.

Cetera Advisors held 935,637 shares of Pfizer worth $26M as of Q1 2024.
Cetera Advisors bought 464,750 Pfizer shares in Q1 2024, an estimated $12.9M.
Pfizer made up 0.2% of Cetera Advisors's portfolio in Q1 2024, its #102 holding.
Cetera Advisors first reported a position in Pfizer in Q2 2013 and has held it in 44 quarters since.
2,874 funds tracked by Wall St. Rank held Pfizer as of Q1 2024.

Based on Cetera Advisors's 13F filing for Q1 2024, filed 15 May 2024.